You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2024

Litigation Details for Onyx Therapeutics, Inc. v. Aurobindo Pharma USA, Inc. (D. Del. 2017)

✉ Email this page to a colleague

« Back to Dashboard

Onyx Therapeutics, Inc. v. Aurobindo Pharma USA, Inc. (D. Del. 2017)

Docket	⤷ Sign Up	Date Filed	2017-11-22
Court	District Court, D. Delaware	Date Terminated	2019-05-08
Cause	35:271 Patent Infringement	Assigned To	Leonard Philip Stark
Jury Demand	None	Referred To
Patents	7,232,818; 7,417,042; 7,491,704; 7,737,112; 8,129,346; 8,207,125; 8,207,126; 8,207,127; 8,207,297; 9,173,857
Link to Docket	External link to docket

Small Molecule Drugs cited in Onyx Therapeutics, Inc. v. Aurobindo Pharma USA, Inc.

The small molecule drugs covered by the patents cited in this case are ⤷ Sign Up and ⤷ Sign Up .

Biologic Drugs cited in Onyx Therapeutics, Inc. v. Aurobindo Pharma USA, Inc.

The biologic drugs covered by the patents cited in this case are ⤷ Sign Up and ⤷ Sign Up .

Details for Onyx Therapeutics, Inc. v. Aurobindo Pharma USA, Inc. (D. Del. 2017)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2017-11-21	1		11. United States Patent No. 7,232,818 (the “’818 Patent”), entitled “Compounds For Enzyme Inhibition…Product prior to the expiration of U.S. Patent Nos. 7,417,042; 7,232,818; 7,491,704; 7,737,112; 8,129,346;… COUNT II: INFRINGEMENT OF U.S. PATENT NO. 7,232,818 47. Plaintiff hereby realleges… THE PATENTS-IN-SUIT 10. United States Patent No. 7,417,042 (the “’042 Patent”), entitled… This is a civil action for patent infringement under the patent laws of the United States, Title	External link to document
2018-03-16	15		warrants that it owns United States Patent No. 7,232,818 (“the ’818 patent”), titled “Compounds for enzyme… and Covenant Not to Sue Regarding U.S. Patent Nos. 7,232,818; 7,491,704; 8,129,346; and 8,207,297 by …NOT TO SUE REGARDING U.S. PATENT NOS. 7,232,818, 7,491,704, 8,129,346, AND 8,207,297 …warrants that it owns United States Patent No. 7,491,704 (“the ’704 patent”), titled “Compounds for enzyme…warrants that it owns United States Patent No. 8,129,346 (“the ’346 patent”), titled “Compounds for enzyme	External link to document
2019-05-08	24	Order	enjoined from infringing United States Patent Numbers 7,417,042, 7,737, 112, and 8,207,125, on its own…November 2017 8 May 2019 1:17-cv-01699 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2017-11-21	4		Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,173,857 B2; 7,232,818 B2; 7,491,704…November 2017 8 May 2019 1:17-cv-01699 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.